About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin for Enhanced Bioprocessing Performance

Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines

Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ Efficient-Pro™ Medium (+) Insulin, a next-generation medium designed to increase titers to maximize productivity and elevate the performance of insulin-dependent CHO cell lines. Efficient-Pro Medium (+) Insulin is the latest addition to Thermo Fisher’s existing Efficient-Pro medium and feed system, designed to provide optimized growth and productivity for insulin-dependent CHO cell lines, with streamlined workflow and handling.

Designed for Biopharma Manufacturers, Biotechnology Companies, and CDMOs Focused on CHO-Based Therapeutics

Efficient-Pro Medium (+) Insulin offers improved protein yield and optimized productivity for insulin-dependent CHO cell lines commonly used in monoclonal antibody and biosimilar production, while also simplifying the preparation process and logistics. Biopharma manufacturers, biotechnology companies, and contract development and manufacturing organizations (CDMOs) can benefit from the following:

  • Industry leaders want higher protein titers - our solution offers up to 61% higher protein titers compared to other alternatives;
  • High viable cell densities and robust growth, all without compromising product quality;
  • Compatibility with a broad range of insulin-dependent CHO cell lines and increased flexibility through a variety of formats and packaging configurations;
  • Dry format compatibility via Thermo Fisher’s Gibco™ Advanced Granulation Technology™ (AGT™) dry media, enabling ease of use, rapid reconstitution and scalability and
  • Animal origin–free (AOF) formulation that reduces process variability and eases regulatory complexity, helping customers achieve dependable results with greater peace of mind.

For protein therapeutic developers (e.g., mAb, bispecific, Fc-fusion proteins, etc.), Efficient-Pro Medium (+) Insulin simplifies process development by providing consistent, high-performance growth and production conditions with reduced variability.

“Our announcement represents a significant enhancement in bioprocessing technology,” said Sara Henneman, vice president and general manager of Thermo Fisher Scientific’s cell culture and cell therapy business. “By integrating our AGT format and ensuring an AOF formulation, we are addressing key industry challenges and providing our customers with a reliable, high-performance solution. Efficient-Pro Medium (+) Insulin underscores our dedication to innovation and our mission to support the development of groundbreaking therapies that improve patient outcomes worldwide.”

Meeting the Needs of a Changing Industry

As the biologics industry pushes for faster development timelines, reduced cost-of-goods, and greater supply chain agility, Efficient-Pro Medium (+) Insulin provides a future-ready solution. It is designed to eliminate the need for manual insulin supplementation, and for robust quality systems that help support supply assurance and confidence in the delivery of consistent, high-quality products — further simplifying the bioproduction process for customers.

“With Efficient-Pro Medium (+) Insulin, we’re building on our commitment to remove barriers in bioproduction and help our customers achieve more,” said Andy Campbell, senior director of research and development at Thermo Fisher Scientific. “This latest innovation enables our customers to scale up rapidly, adapt to evolving project needs, and accelerate the delivery of life-changing therapies to patients. Efficient-Pro Medium (+) Insulin delivers on that promise by providing the tools and support needed to streamline processes, minimize risk and bring new treatments to market faster and more efficiently than ever before.”

To learn more about Efficient-Pro Medium (+) Insulin, please visit the product website.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of more than $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

  1. Based on internal testing.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.